Why a Major Fund Cut Its Stake in This REIT Still Down 70% Since 2007

New York City-based Argosy-Lionbridge Management trimmed its Veris Residential stake in Q3, selling 372,132 shares (about $5.5m) and ending the quarter with 265,413 shares valued at roughly $4m, or 2.7% of reportable AUM. Veris shares trade at $14.18, down ~19% over the past year, even as the REIT posted operational improvements — Q3 net income of $0.80 per diluted share (versus a loss a year earlier), occupancy up to 94.7%, 3.9% blended rental growth, raised FFO guidance, and $542m of dispositions used to retire $394m of debt — but it still carries a high normalized net debt-to-EBITDA (~10x). The move is consistent with Argosy’s preference for larger, steadier industrial and multifamily holdings and underscores investor focus on whether Veris can execute faster deleveraging and asset sales to close its valuation gap.

Analysis

Argosy‑Lionbridge Management sold 372,132 Veris Residential (VRE) shares in Q3, trimming its stake by about $5.5 million and leaving 265,413 shares valued at roughly $4.0 million as of September 30; the holding now represents 2.7% of its reportable AUM. VRE shares closed at $14.18 in the referenced trading session, roughly 19% below the prior year and well behind the S&P 500’s performance, against a market capitalization of $1.6 billion.

Veris reported tangible operational improvement in Q3: net income of $0.80 per diluted share versus a loss of $0.10 a year earlier, occupancy rising to 94.7%, 3.9% blended rental growth, reaffirmed same‑store revenue guidance of 2.2%–2.7%, and increased FFO guidance, while executing $542 million of dispositions to retire $394 million of debt and lower interest costs. Despite these positives, the company is described as carrying normalized net debt-to-EBITDA near 10x and remains reliant on asset sales to delever, keeping balance‑sheet risk elevated.

Argosy’s trim is consistent with a portfolio tilt toward larger, steadier industrial and multifamily names and signals cautious positioning around leverage and execution risk; the market reaction and available metrics imply mixed sentiment and limited near‑term upside until deleveraging progress is confirmed. Key monitorables for investors are the pace and permanence of asset sales, FFO and occupancy trends, and measurable reductions in leverage that would justify a re‑weighting.

Key Decisions for Investors

• Avoid increasing a concentrated position in VRE until the company demonstrates sustained deleveraging (material drops in net debt-to-EBITDA) and consistent FFO beats,
• Monitor quarterly indicators — FFO guidance, realized proceeds from asset dispositions, same-store revenue growth and occupancy — as primary catalysts that would reduce balance-sheet risk,
• Consider a small, staged entry or hedged exposure if seeking upside from the valuation gap, but prioritize risk management given reliance on asset sales and elevated leverage